Related Experiment Video
Updated: May 15, 2026

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
Published on: July 20, 2022
[Pathogenic bacteria and drug resistance in peritoneal dialysis related peritonitis]
Weisheng Peng1, Qiaoling Zhou, Xiang Ao
1Department of Nephrology, Central South University, Changsha, China.
Objective:
To investigate the pathogens and their resistance in continuous ambulatory peritoneal dialysis (CAPD) related peritonitis.
Methods:
A total of 78 cases with CAPD related peritonitis from Xiangya Hospital between January 2007 and January 2011 were reviewed. Pathogens, resistance and outcomes of the 78 cases CAPD related peritonitis were analyzed retrospectively.
Results:
Among them, 53 cases cultured positive (66.67%), 3 of which were combined infection and 2 strains were cultured. A total of 55 strains were cultured, including 32 gram-positive strains (58.18%), 18 gram-negative strains (32.72%) and 5 fungi (9.09%). The most common pathogens were coagulase negative staphylococcus, staphylococcus aureus and Escherichia coli. Drug sensitivity test of the gram-positive strains showed that the three with lowest antibiotic resistance were linezolid (0), teicoplanin (3.13%) and vancomycin (4.0%). Drug sensitivity test of the gram-negative bacteria showed that antibiotics with the lowest resistance were amikacin and imipenem, followed by piperacillin/tazobactam and cepoperazon/sulbactam. Cephazolin had the highest resistance rate of 83.33%. Clinical outcomes: 63 cases cured (80.77%); 11 cases transferred to hemodialysis (14.1%); 4 cases died (5.13%), including 2 cases fungus infections, 1 gram-negative bacteria infection and 1 combined infection.
Conclusion:
The most common pathogens causing peritoneal dialysis associated peritonitis is gram positive bacteria. In the empirical treatment, in addition to traditional treatment of Cefazolin combined with aminoglycosides, cefazolin combined with piperacillin/tazobactam or cepoperazon/sulbactam is preferable for CAPD associated peritonitis.
Insights
Gram-positive bacteria are the most common cause of continuous ambulatory peritoneal dialysis (CAPD) peritonitis. For empirical treatment, consider cefazolin with piperacillin/tazobactam or cepoperazon/sulbactam for better outcomes.
Area of Science:
- Nephrology
- Infectious Diseases
- Microbiology
Context:
- Peritonitis is a serious complication of continuous ambulatory peritoneal dialysis (CAPD).
- Understanding causative pathogens and their antibiotic resistance is crucial for effective management.
- This study reviews cases from Xiangya Hospital (2007-2011).
Purpose:
- To identify the primary pathogens responsible for CAPD-related peritonitis.
- To analyze the antibiotic resistance patterns of these pathogens.
- To evaluate the clinical outcomes of CAPD peritonitis treatments.
Summary:
- A retrospective analysis of 78 CAPD peritonitis cases revealed gram-positive bacteria as the most frequent pathogens (58.18%), followed by gram-negative bacteria (32.72%) and fungi (9.09%).
- Key pathogens included coagulase-negative staphylococcus, Staphylococcus aureus, and Escherichia coli.
- Antibiotic resistance patterns indicated linezolid, teicoplanin, and vancomycin were effective against gram-positive strains, while amikacin and imipenem showed low resistance in gram-negative strains. Cefazolin exhibited high resistance (83.33%).
- Treatment outcomes included 80.77% cure rates, 14.1% transfers to hemodialysis, and 5.13% mortality.
Impact:
- Findings guide empirical antibiotic selection for CAPD peritonitis, suggesting cefazolin combined with piperacillin/tazobactam or cepoperazon/sulbactam as preferable alternatives.
- Highlights the need for ongoing surveillance of pathogen prevalence and resistance patterns in CAPD populations.
- Informs clinical decision-making to improve patient outcomes and reduce complications associated with CAPD peritonitis.
Related Concept Videos
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Mechanism of Antibiotic Resistance in MRSA
Development of Antibiotic Resistance
Peritoneal Dialysis III: Nursing Management
Acute Pyelonephritis II: Diagnostic Studies and Management
Clinical Significance of Antibiotic Resistance

